Beris Photis, Picard Véronique
Service d'Hématologie, Département de Médecine Interne, Centre Médical Universitaire Genève Suisse, Geneva, Switzerland; Département d'hématologie, Laboratoire central Unilabs, Coppet, Switzerland.
Service d'Hématologie biologique, Hôpital Bicêtre, AP-HP, Le Kremlin Bicêtre, France; Laboratoire d'Hématologie, Faculté de Pharmacie, Université Paris-Sud, France.
Semin Hematol. 2015 Oct;52(4):287-303. doi: 10.1053/j.seminhematol.2015.07.005. Epub 2015 Jul 21.
Non-immune hemolytic anemia (NIHA) is characterized by positive routine hemolytic tests but negative anti-human immunoglobulin (Coombs) test. Hereditary non-immune hemolysis includes disorders of erythrocytic enzymes, membrane, hemoglobin (qualitative and quantitative disorders), as well as the rare hereditary forms of thrombotic microangiopathies. Acquired NIHA includes paroxysmal nocturnal hemolysis (PNH), infections, drug and metal intoxications with as a target red blood cells or endothelium of capillaries, the rare acquired forms of thalassemia or erythrocytic membrane disorders, and hemolysis secondary to a dysfunctioning artificial (prosthetic) cardiac valve. Identification of the specific cause of NIHA is sometimes difficult and requires not only a good knowledge of this entity but mainly a qualified specialized hematologic laboratory. An algorithm to be used in every new patient consulting for NIHA is proposed in the last part of this article.
非免疫性溶血性贫血(NIHA)的特征是常规溶血试验呈阳性,但抗人球蛋白(库姆斯)试验呈阴性。遗传性非免疫性溶血包括红细胞酶、膜、血红蛋白(定性和定量紊乱)的疾病,以及罕见的遗传性血栓性微血管病形式。获得性NIHA包括阵发性夜间溶血(PNH)、感染、以红细胞或毛细血管内皮为靶标的药物和金属中毒、罕见的获得性地中海贫血或红细胞膜疾病形式,以及继发于功能异常的人工(假体)心脏瓣膜的溶血。确定NIHA的具体病因有时很困难,不仅需要对该疾病有充分了解,主要还需要合格的专业血液学实验室。本文最后部分提出了用于每一位咨询NIHA的新患者的算法。